ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 3 filers reported holding ARCUS BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,786,181 | +11.4% | 1,436,515 | +26.1% | 0.01% | +14.3% |
Q2 2023 | $23,141,100 | -2.9% | 1,139,480 | -12.8% | 0.01% | -12.5% |
Q1 2023 | $23,839,290 | +115861.1% | 1,307,077 | +31.5% | 0.01% | +33.3% |
Q4 2022 | $20,558 | -99.9% | 994,190 | +46.2% | 0.01% | -14.3% |
Q3 2022 | $17,791,000 | +119.0% | 680,094 | +112.0% | 0.01% | +133.3% |
Q2 2022 | $8,125,000 | -41.2% | 320,755 | -26.8% | 0.00% | -25.0% |
Q1 2022 | $13,826,000 | +38.0% | 437,969 | +77.0% | 0.00% | +33.3% |
Q4 2021 | $10,016,000 | +638.6% | 247,442 | +536.1% | 0.00% | – |
Q3 2021 | $1,356,000 | +41.8% | 38,899 | +11.8% | 0.00% | – |
Q2 2021 | $956,000 | -81.5% | 34,800 | -82.5% | 0.00% | -100.0% |
Q4 2020 | $5,162,000 | -6.8% | 198,754 | -38.5% | 0.00% | 0.0% |
Q3 2020 | $5,537,000 | -4.3% | 323,038 | +38.2% | 0.00% | -33.3% |
Q2 2020 | $5,783,000 | +77.6% | 233,744 | -0.4% | 0.00% | +50.0% |
Q1 2020 | $3,257,000 | +70.9% | 234,653 | +24.3% | 0.00% | +100.0% |
Q4 2019 | $1,906,000 | +207.9% | 188,716 | +177.3% | 0.00% | – |
Q3 2019 | $619,000 | – | 68,060 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $40,850,000 | 24.66% |
Octagon Capital Advisors LP | 2,669,974 | $67,657,000 | 18.06% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $22,040,000 | 8.36% |
BVF INC/IL | 3,960,948 | $100,370,000 | 4.85% |
Finepoint Capital LP | 535,000 | $13,557,000 | 4.69% |
PFM Health Sciences, LP | 3,346,458 | $84,799,000 | 3.24% |
ACUTA CAPITAL PARTNERS, LLC | 167,500 | $4,244,000 | 2.36% |
Boxer Capital, LLC | 1,432,200 | $36,292,000 | 2.30% |
Parkman Healthcare Partners LLC | 171,214 | $4,339,000 | 1.60% |
SECTORAL ASSET MANAGEMENT INC | 311,782 | $7,901,000 | 1.59% |